U.S. Physical Therapy’s (USPH) “Outperform” Rating Reiterated at Barrington Research

U.S. Physical Therapy (NYSE:USPH)‘s stock had its “outperform” rating reaffirmed by analysts at Barrington Research in a research report issued on Friday, Benzinga reports. They presently have a $108.00 target price on the stock. Barrington Research’s price objective indicates a potential upside of 27.98% from the company’s current price.

Separately, StockNews.com upgraded U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Wednesday, August 21st.

U.S. Physical Therapy Trading Down 0.7 %

USPH stock traded down $0.63 during trading on Friday, reaching $84.39. 40,709 shares of the stock traded hands, compared to its average volume of 87,029. The firm has a market capitalization of $1.27 billion, a PE ratio of 68.61, a P/E/G ratio of 4.11 and a beta of 1.39. The company has a debt-to-equity ratio of 0.28, a current ratio of 1.88 and a quick ratio of 1.88. The business’s 50 day moving average price is $88.83 and its 200-day moving average price is $97.24. U.S. Physical Therapy has a 52-week low of $78.08 and a 52-week high of $113.63.

U.S. Physical Therapy (NYSE:USPH) last posted its earnings results on Tuesday, August 13th. The company reported $0.73 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.82 by ($0.09). The business had revenue of $167.19 million for the quarter, compared to analyst estimates of $163.34 million. U.S. Physical Therapy had a return on equity of 8.18% and a net margin of 4.06%. The firm’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same period last year, the company posted $0.76 EPS. As a group, sell-side analysts forecast that U.S. Physical Therapy will post 2.51 earnings per share for the current year.

Insider Transactions at U.S. Physical Therapy

In related news, COO Graham D. Reeve sold 1,724 shares of the stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $82.50, for a total transaction of $142,230.00. Following the sale, the chief operating officer now owns 7,038 shares in the company, valued at $580,635. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,724 shares of the business’s stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $82.50, for a total transaction of $142,230.00. Following the completion of the transaction, the chief operating officer now owns 7,038 shares in the company, valued at approximately $580,635. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Kathleen A. Gilmartin acquired 2,000 shares of U.S. Physical Therapy stock in a transaction that occurred on Tuesday, September 3rd. The stock was bought at an average cost of $86.09 per share, with a total value of $172,180.00. Following the acquisition, the director now directly owns 18,904 shares of the company’s stock, valued at $1,627,445.36. The disclosure for this purchase can be found here. Insiders own 1.70% of the company’s stock.

Institutional Trading of U.S. Physical Therapy

Several institutional investors and hedge funds have recently bought and sold shares of USPH. Silvercrest Asset Management Group LLC purchased a new stake in shares of U.S. Physical Therapy in the first quarter valued at $8,158,000. RK Capital Management LLC acquired a new stake in U.S. Physical Therapy during the 4th quarter worth about $6,166,000. Renaissance Technologies LLC boosted its position in U.S. Physical Therapy by 763.7% during the 2nd quarter. Renaissance Technologies LLC now owns 69,523 shares of the company’s stock worth $6,425,000 after acquiring an additional 61,474 shares during the period. Norden Group LLC increased its holdings in shares of U.S. Physical Therapy by 1,841.6% in the 1st quarter. Norden Group LLC now owns 63,938 shares of the company’s stock valued at $7,217,000 after purchasing an additional 60,645 shares during the period. Finally, Schroder Investment Management Group lifted its position in shares of U.S. Physical Therapy by 11.0% in the fourth quarter. Schroder Investment Management Group now owns 427,217 shares of the company’s stock worth $39,791,000 after purchasing an additional 42,281 shares in the last quarter.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.